SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Interdent Inc – ‘8-K’ for 5/9/03 – EX-99.3

On:  Monday, 5/12/03, at 9:56pm ET   ·   As of:  5/13/03   ·   For:  5/9/03   ·   Accession #:  1104659-3-9220   ·   File #:  0-25549

Previous ‘8-K’:  ‘8-K’ on / for 9/20/01   ·   Next:  ‘8-K’ on 10/10/03 for 10/9/03   ·   Latest:  ‘8-K’ on 3/20/07 for 3/19/07

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/13/03  Interdent Inc                     8-K:3,7     5/09/03    4:809K                                   Merrill Corp-MD/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     26K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    407K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML     16K 
 4: EX-99.3     Miscellaneous Exhibit                               HTML    127K 


EX-99.3   —   Miscellaneous Exhibit


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



EXHIBIT 99.3

 

INTERDENT, INC.

 

CONSOLIDATED STATEMENTS OF OPERATIONS

 

(Unaudited, in thousands)

 

 

 

One Month Ended

January 31, 2­­003

 

One Month Ended

February 28, 2003

 

One Month Ended

March 31, 2003

 

Three Months Ended
March 31, 2003

 

 

 

 

 

 

 

 

 

$

 

% Rev

 

$

 

% Rev

 

$

 

% Rev

 

$

 

% Rev

 

Practice patient revenue

 

$

21,002

 

100.2

%

$

18,828

 

100.1

%

$

19,265

 

100.0

%

$

59,095

 

100.1

%

Consulting & licensing fees

 

47

 

0.2

%

47

 

0.2

%

47

 

0.2

%

141

 

0.2

%

Amounts retained by dentist

 

90

 

0.4

%

60

 

0.3

%

49

 

0.3

%

199

 

0.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

20,959

 

100.0

%

18,815

 

100.0

%

19,263

 

100.0

%

59,037

 

100.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dental practice net patient service revenue

 

$

20,827

 

99.4

%

$

18,689

 

99.3

%

$

19,133

 

99.3

%

58,649

 

99.3

%

Net management fees

 

85

 

0.4

%

79

 

0.4

%

83

 

0.4

%

247

 

0.4

%

Consulting & licensing fees

 

47

 

0.2

%

47

 

0.2

%

47

 

0.2

%

141

 

0.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

20,959

 

100.0

%

18,815

 

100.0

%

19,263

 

100.0

%

59,037

 

100.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Clinical salaries and benefits

 

10,666

 

50.9

%

9,379

 

49.8

%

9,302

 

48.3

%

29,347

 

49.7

%

Practice nonclinical salaries and benefits

 

2,819

 

13.5

%

2,670

 

14.2

%

2,597

 

13.5

%

8,086

 

13.7

%

Dental supplies and lab expenses

 

2,112

 

10.1

%

2,128

 

11.3

%

2,163

 

11.2

%

6,403

 

10.8

%

Practice occupancy expenses

 

1,111

 

5.3

%

1,148

 

6.1

%

1,150

 

6.0

%

3,409

 

5.8

%

Practice selling, general and administrative expenses

 

1,628

 

7.8

%

1,573

 

8.4

%

1,589

 

8.2

%

4,790

 

8.1

%

Corporate selling, general and administrative expenses

 

971

 

4.6

%

1,014

 

5.4

%

1,285

 

6.7

%

3,270

 

5.5

%

Stock compensation expense

 

 

0.0

%

 

0.0

%

 

0.0

%

 

0.0

%

Corporate restructure and merger costs

 

 

0.0

%

 

0.0

%

 

0.0

%

 

0.0

%

Writedown of long-lived assets

 

 

0.0

%

 

0.0

%

 

0.0

%

 

0.0

%

Depreciation and amortization

 

320

 

1.5

%

318

 

1.7

%

317

 

1.6

%

955

 

1.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

19,627

 

93.6

%

18,230

 

96.9

%

18,403

 

95.5

%

56,260

 

95.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

1,332

 

6.4

%

585

 

3.1

%

860

 

4.5

%

2,777

 

4.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nonoperating income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

(2,162

)

-10.3

%

(2,050

)

-10.9

%

(2,115

)

-11.0

%

(6,327

)

-10.7

%

Other expense, net

 

(1

)

0.0

%

(23

)

-0.1

%

 

0.0

%

(24

)

0.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nonoperating expense, net

 

(2,163

)

-10.3

%

(2,073

)

-11.0

%

(2,115

)

-11.0

%

(6,351

)

-10.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) before income taxes and extraordinary item

 

(831

)

-4.0

%

(1,488

)

-7.9

%

(1,255

)

-6.5

%

(3,574

)

-6.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

0.0

%

 

0.0

%

 

0.0

%

 

0.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) before extraordinary item

 

(831

)

-4.0

%

(1,488

)

-2.5

%

(1,255

)

-6.5

%

(3,574

)

-6.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Extraordinary items—Debt Extinguishment, net of income taxes

 

 

0.0

%

 

0.0

%

 

0.0

%

 

0.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributed to common stock

 

$

(831

)

-4.0

%

$

(1,488

)

-2.5

%

$

(1,255

)

-6.5

%

$

(3,574

)

-6.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Facility EBITDA

 

$

2,623

 

12.5

%

$

1,917

 

10.2

%

$

2,462

 

12.8

%

$

7,002

 

11.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate EBITDA

 

$

1,652

 

7.9

%

$

903

 

4.8

%

$

1,177

 

6.1

%

$

3,732

 

6.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed as of:5/13/03
Filed on:5/12/03
For Period End:5/9/03
3/31/0310-Q,  NT 10-K,  NT 10-Q
2/28/03
 List all Filings 
Top
Filing Submission 0001104659-03-009220   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 5:04:17.1pm ET